CYNTHIA REMY: Open Payments
NPI 1811509920 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 82 payments from 35 companies in 2025. Trend: 2023 $1,608 · 2024 $2,208 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $287 |
| PFIZER INC. | 16 | $267 |
| GENZYME CORPORATION | 4 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Genentech USA, Inc. | 3 | $76 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Celgene Corporation | 3 | $71 |
| ABBVIE INC. | 2 | $58 |
| Eisai Inc. | 3 | $53 |
| TAIHO ONCOLOGY, INC. | 2 | $53 |
Products named: KEYTRUDA, IBRANCE, ELREXFIO, WELIREG, REBLOZYL, XTANDI, ELAHERE, Lenvima.
Industry payments across FL — which companies pay providers there.
